BIP CVC Clinical Safety and Performance Study

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
SurgeryCentral Line Associated Blood Stream Infections (CLABSI)
Interventions
DEVICE

BIP CVC

BIP CVC catheterization to minimize risk of infections for venous access during and after elective large surgery

DEVICE

Uncoated Standard CVC

Standard CVC catheterization for venous access during and after elective large surgery

Trial Locations (1)

SE-141 86

Karolinska University Hospital, Dept. of Anesthesia and Intensive Care, Sweden, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

lead

Bactiguard AB

INDUSTRY

NCT02811380 - BIP CVC Clinical Safety and Performance Study | Biotech Hunter | Biotech Hunter